Uwe Schön is the Director of BioMedHeliX.The most important innovation of the company is the latest innovations to address the challenge of cryostorage for COVID vaccines.BioMedHeliX is also a designer of biobanks and the related processes. The partnership with the German manufacturer Cryotherm ensures access to the best products and know how in the market.Uwe Schön started his career at the Fraunhofer Institute for Biomedical Technology (IBMT) where he developed mobile clinics and laboratories. He headed up the development of the first mobile BSL3 (Bio Safety Level 3) laboratory, that has been active in South Africa since 2010 in HIV and TB VTC projects. - See more at: https://biomedhelix.com He was also involved in the development and design of cryotechnology and biobanks. In 2008 a biobank, based on this technology was installed at the University of Stellenbosch, Department of Virology. This biobank serves as a storage for patients virus samples. As a result of his longterm relationship and collaboration with the German manufacturer for cryostorage equipment CRYOTHERM, BioMedHeliX is their official South African distributor. See more at http://cryotherm.de/en/